Validating new symptom emergence as a patient-centric outcome measure for PD clinical trials.

Saved in:
Bibliographic Details
Title: Validating new symptom emergence as a patient-centric outcome measure for PD clinical trials.
Authors: Zou H; Department of Biostatistics & Bioinformatics, Duke University, Durham, NC, 27705, USA. Electronic address: haotian.zhu@duke.edu., Stebbins GT; Professor Emeritus, Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, USA. Electronic address: Glenn_Stebbins@rush.edu., Simuni T; Parkinson's disease and Movement Disorders Center, Northwestern University Feinberg School of Medicine, 710 North Lake Shore Drive, Chicago IL, 60611, USA. Electronic address: Tatyana.Simuni@nm.org., Luo S; Department of Biostatistics & Bioinformatics, Duke University, Durham, NC, 27705, USA. Electronic address: sheng.luo@duke.edu., Cedarbaum JM; Division of Movement Disorders, Department of Neurology, Yale School of Medicine, New Haven CT 06511, USA. Electronic address: jesse.cedarbaum@yale.edu.
Source: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2024 Nov; Vol. 128, pp. 107118. Date of Electronic Publication: 2024 Sep 10.
Publication Type: Journal Article; Validation Study; Clinical Trial, Phase III
Journal Info: Publisher: Elsevier Science Country of Publication: England NLM ID: 9513583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5126 (Electronic) Linking ISSN: 13538020 NLM ISO Abbreviation: Parkinsonism Relat Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5126
DOI:10.1016/j.parkreldis.2024.107118